
Ubiquitinação
Os inibidores de ubiquitinação são compostos que interferem no processo de ubiquitinação, onde as proteínas são marcadas com moléculas de ubiquitina para degradação pelo proteassoma. Esses inibidores são críticos para o estudo da renovação de proteínas, transdução de sinais e regulação de vários processos celulares. A ubiquitinação desempenha um papel fundamental em muitas doenças, incluindo câncer, distúrbios neurodegenerativos e disfunções do sistema imunológico. Ao modular a ubiquitinação, esses inibidores podem fornecer insights sobre os mecanismos das doenças e abrir novas vias para intervenções terapêuticas. Na CymitQuimica, oferecemos uma ampla seleção de inibidores de ubiquitinação de alta qualidade para apoiar sua pesquisa em biologia celular, proteômica e descoberta de medicamentos.
Subcategorias de "Ubiquitinação"
Foram encontrados 65 produtos para "Ubiquitinação".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
WS-383
CAS:WS-383 is a selective, potent and reversible DCN1-UBC12 interaction inhibitor(IC50 of 11 nM).Fórmula:C18H21Cl2N9S2Pureza:98.46%Cor e Forma:SolidPeso molecular:498.46Ref: TM-T13349
1mg43,00€2mg55,00€1mL*10mM (DMSO)92,00€5mg93,00€10mg137,00€25mg268,00€50mg530,00€100mg755,00€500mg1.549,00€ML-792
CAS:ML-792 is a specific small ubiquitin-like modifier activating enzyme (SUMO) inhibitor.Cost-effective and quality-assured.Fórmula:C21H23BrN6O5SPureza:99.32% - 99.82%Cor e Forma:SolidPeso molecular:551.41Ref: TM-T16102
1mg87,00€2mg113,00€5mg177,00€1mL*10mM (DMSO)225,00€10mg260,00€25mg409,00€50mg560,00€100mg800,00€NSC232003
CAS:NSC232003 is a highly potent and cell-permeable inhibitor of UHRF1.Fórmula:C6H7N3O3Pureza:97.72%Cor e Forma:SolidPeso molecular:169.14Post-Translational Modification Compound Library
Contains xnum active small molecules for research related to post-translational modifications (PTMs);
Cor e Forma:Odour SolidRef: TM-L1620
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarSkp2 inhibitor 3
Skp2 inhibitor 3 (E35), a potent antitumor agent, acts as a robust inhibitor of S-phase kinase-associated protein 2 (SKP2) with an IC50 of 4.86 μM for Skp2-Cks1 binding. It significantly suppresses colony formation and migration, while inducing cell cycle arrest in the S-phase.Cor e Forma:Odour SolidUP12
CAS:UP12 enhances ATPase activity by activating valosin-containing protein (VCP), with an EC50 of 2.57 μM.Fórmula:C23H16ClN3O3SCor e Forma:SolidPeso molecular:449.91Cbl-b-IN-18
Cbl-b-IN-18 (compound 51) is an inhibitor of the E3 ubiquitin ligase Cbl-b, effectively blocking Cbl-b phosphorylation with an IC50 of less than 100 nM.Fórmula:C33H31F4N7OCor e Forma:SolidPeso molecular:617.25262Ubiquitination Compound Library
A unique collection of xnum ubiquitination related small chemicals can be used for high throughput and high content screening;Cor e Forma:Odour SolidRef: TM-L8600
1mgA consultar10μL*10mM (DMSO)A consultar20μL*10mM (DMSO)A consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarUP158
CAS:UP158 enhances ATPase activity and stimulates valosin-containing protein (VCP), with an EC50 of 2.57 μM.Fórmula:C17H17ClN4O2Cor e Forma:SolidPeso molecular:344.8RNF5 agonist 1
CAS:RNF5 agonist 1 (analog-1), a structural analog of the RNF5 inhibitor inh-02, is a potent RNF5 agonist. In CFBE41o- cells expressing F508del-CFTR, RNF5 agonist 1 enhances the ubiquitination of ATG4B.Fórmula:C22H18N4SCor e Forma:SolidPeso molecular:370.47dCeMM3
CAS:dCeMM3 is a glue degrader that induces ubiquitination and degradation of cyclin K by promoting CDK12-cyclin K interaction with CRL4B ligase.Fórmula:C14H11ClN4OSPureza:98.48% - 99.49%Cor e Forma:SolidPeso molecular:318.78Cbl-b-IN-15
Cbl-b-IN-15 (compound 25) is an inhibitor of the RING finger E3 ubiquitin ligase Cbl, demonstrating an IC50 of 15 nM. Cbl-b refers to Casitas B-lineage Lymphoma proto-oncogene-b, which can inhibit the activation of T cells, natural killer (NK) cells, and B cells. Cbl-b-IN-15 can activate T cell function with an EC50 of 0.41 μM.Fórmula:C27H27N5O3Cor e Forma:SolidPeso molecular:469.21139Cbl-b-IN-19
Cbl-b-IN-19 (Compound 49) is an inhibitor of the E3 ligase Cbl-b, effectively suppressing its phosphorylation with an IC50 of less than 100 nM.Fórmula:C34H31F3N8OCor e Forma:SolidPeso molecular:624.25729SAE-IN-2
SAE-IN-2 (compound 6) is a potent inhibitor of sumoylation-activating enzyme (SAE) with an IC50 value of 27.8 nM.Fórmula:C27H30ClN5O5S2Cor e Forma:SolidPeso molecular:603.13769UP163
CAS:UP163 enhances ATPase activity and activates valosin-containing protein (VCP), with an EC50 of 9.0 μM. It also reduces MG-132-induced TDP-43 aggregation.Fórmula:C20H15ClN2O5SCor e Forma:SolidPeso molecular:430.86Antitumor agent-153
Antitumor agent-153 (compound 11b) is an inhibitor of H2A histone ubiquitination, optimized from PRT4165. It can reduce the viability of human osteosarcoma U2OS cells and decrease monoubiquitination of histone H2A, demonstrating anticancer activity.Fórmula:C16H8N2O6Cor e Forma:SolidPeso molecular:324.03824MSC1094308
CAS:MSC1094308 is a reversible, non-ATP-competitive inhibitor targeting type II AAA ATPase (VCP/p97) and type I AAA ATPase (VPS4B) and affects protein degradation.Fórmula:C29H29F3N2Cor e Forma:SolidPeso molecular:462.55LS-102
CAS:LS-102: E3 ligase inhibitor, IC50 35 μM, potential RA therapy.Fórmula:C24H36N8OPureza:98.92%Cor e Forma:SolidPeso molecular:452.6Ref: TM-T11879
1mg47,00€5mg92,00€1mL*10mM (DMSO)101,00€10mg145,00€25mg256,00€50mg409,00€100mg590,00€200mg827,00€ML240
CAS:ML240 is a selective, ATP-competitive p97 inhibitor.Fórmula:C23H20N6OPureza:99.73% - >99.99%Cor e Forma:White SolidPeso molecular:396.44Ref: TM-T3535
1mg35,00€2mg50,00€5mg77,00€1mL*10mM (DMSO)84,00€10mg105,00€25mg178,00€50mg295,00€100mg477,00€200mg677,00€CYM5442
CAS:CYM5442 is an S1P agonist, targeting to Sphingosine.Fórmula:C23H27N3O4Pureza:98.02% - 99.48%Cor e Forma:White SolidPeso molecular:409.48

